Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Revenue

Appili Therapeutics had revenue of 114.98K CAD in the quarter ending December 31, 2025, with 6.11% growth. This brings the company's revenue in the last twelve months to 206.31K, up 65.38% year-over-year. In the fiscal year ending March 31, 2025, Appili Therapeutics had annual revenue of 100.44K, down -87.86%.

• Revenue (ttm): 206.31K
• Revenue Growth: +65.38%
• P/S Ratio: 9.62
• Revenue / Employee: 29.47K
• Employees: 7
• Market Cap: 1.99M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	100.44K	-726.96K	-87.86%
Mar 31, 2024	827.41K	493.23K	147.60%
Mar 31, 2023	334.18K	-1.06M	-75.97%
Mar 31, 2022	1.39M	-	-
Mar 31, 2021	-	-	-